ALBT — Avalon Globocare Cashflow Statement
0.000.00%
Last trade - 00:00- $6.13m
- $34.60m
- $1.33m
- 36
- 20
- 28
- 17
Annual cashflow statement for Avalon Globocare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.7 | -9.09 | -11.9 | -16.7 | -7.9 |
| Depreciation | |||||
| Non-Cash Items | 5.67 | 2.25 | 4.36 | 10 | 3.99 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.856 | 1.5 | 0.207 | -0.035 | -1.23 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -7.55 | -5.02 | -7.04 | -6.5 | -4.97 |
| Capital Expenditures | -0.111 | -0.028 | -0.002 | -0.022 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.058 | -0.04 | -9.05 | — | -0.1 |
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.169 | -0.068 | -9.05 | -0.022 | -0.1 |
| Financing Cash Flow Items | -0.54 | -0.24 | -0.291 | 0.139 | 1.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.66 | 5.17 | 17.3 | 4.83 | 7.64 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.038 | 0.081 | 1.18 | -1.71 | 2.57 |